By Nick Carmichael
The laboratory diagnosis of pancreatic disease in dogs and cats has taken has made some significant progress in the last few years. Exocrine pancreatic insufficiency (EPI) is now recognised in both dogs and cats and while most affected animals are young there are a number of older animals that are affected. The canine Trypsin-Like Immunoreactivity (TLI) test is both sensitive and specific for EPI and is assayed as part of the canine intestinal profile together with folate and cobalamin. Feline TLI has been shown similarly to be an excellent assay for EPI in cats, however this test is currently available only in the
The laboratory diagnosis of canine pancreatitis is complicated by the fact that amylase and lipase quickly return to normal following the onset of clinical signs – so normal results need not exclude pancreatitis. In addition, mild increases in amylase and lipase can be seen with intestinal and hepatic disease and both are affected by reduced renal function. As a result these tests are neither completely sensitive nor specific.
In cats with pancreatitis amylase and lipase are only occasionally abnormal and they are considered of little diagnostic value in this species.
Pancreatic lipase immunoreactivity (PLI) however, holds out considerably more promise for the diagnosis of pancreatitis in the dog and cat. In dogs, PLI elevations appear to persist for longer than other tests and this is now considered the best test for chronic pancreatitis. In cats with pancreatitis, PLI has been reported to be more sensitive than TLI (70% vs. 30%). This is particularly useful in cats as the clinical signs in this species are often non-specific (lethargy, anorexia, dehydration) with only 35% showing vomiting and 25% showing abdominal pain.
Currently the PLI assay is only available in the
About the Author
Nick graduated from
No comments:
Post a Comment